ATTO
Attovia Therapeutics, Inc. Common Stock
Nasdaq · usd
Attovia Therapeutics, Inc. Common Stock (ATTO) trades at $15.53 (+4.51%) as of 5:19:45 PM EST on Nov 18, 2026, +10.61% over the past month. Market cap is $709.92M, with 4.5 days to cover in short interest.
Stock performance
How Attovia Therapeutics, Inc. Common Stock (ATTO) stock has performed from one day to one year, with its 52-week range.
- 1D
- +4.51%
- 1W
- -7.17%
- 1M
- +10.61%
- YTD
- -29.09%
- 1Y
- -29.09%
- 52-wk range
- $12.94 – $28.00
Key statistics
Today's trading snapshot for ATTO: day range, open, previous close, volume and market cap.
- Day range
- $14.30 – $16.35
- Open
- $14.60
- Prev close
- $14.86
- Volume
- 337.17K
- Market cap
- $709.92M
- Shares out
- 45.71M
8-K filings
Material corporate events Attovia Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Clinical trial resultsNov 9, 2026
The Company recently announced positive topline 12-week results from its Phase 1b study of ATTO-1310, a next-generation anti-IL-31 ATTOBODY-based precision itch therapy, in patients with chronic pruritus ("CP") and high-itch atopic dermatitis ("AD").
- Quarterly earningsSep 2, 2026
On September 2, 2026, Attovia Therapeutics, Inc. (the "Company") issued a press release reporting its financial results for the second quarter ended June 30, 2026.
- Charter amendmentAug 6, 2026
On August 6, 2026, Attovia Therapeutics, Inc. (the "Company") filed its Amended and Restated Certificate of Incorporation (the "Charter") with the Secretary of State of the State of Delaware...in connection with the closing of the initial public offering (the "Offering") of shares of the Company's common stock.
Dividend history and stock splits
Attovia Therapeutics, Inc. Common Stock's recent dividend payments and stock splits.
Dividends
- $0.34ex-div Nov 9, 2017
Splits
- 1-for-5.0270904666729Jul 30, 2020
ATTO short interest
How heavily ATTO is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 4.5
- Short interest
- 1.59M
- Avg volume
- 352.56K
As of · reported to FINRA twice monthly.
ATTO news
The latest news and headlines about Attovia Therapeutics, Inc. Common Stock (ATTO).
- Why Nocera Are Trading Higher By Around 89%; Here Are 20 Stocks Moving PremarketBenzinga· Jul 5, 2023
- Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's SessionBenzinga· Jul 3, 2023
- Nasdaq Edges Lower; ISM Manufacturing PMI Drops In JuneBenzinga· Jul 3, 2023
- Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionBenzinga· May 30, 2023
- Penny Stocks To Buy? 3 AI Stocks To Watch Right NowPennyStocks· May 30, 2023
Frequently asked questions
What is the Attovia Therapeutics, Inc. Common Stock (ATTO) stock price today?
Attovia Therapeutics, Inc. Common Stock (ATTO) is trading at $15.53 (+4.51% on the day) as of 5:19:45 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Attovia Therapeutics, Inc. Common Stock?
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases.
What is the short interest in ATTO?
As of Oct 30, 2026, ATTO has 1.59M shares short and 4.5 days to cover.
Does Attovia Therapeutics, Inc. Common Stock (ATTO) pay a dividend?
Yes. Attovia Therapeutics, Inc. Common Stock (ATTO)'s most recent dividend was $0.34 per share, with an ex-dividend date of Nov 9, 2017. Full ATTO dividend history is available from the Massive API.
What exchange is ATTO listed on?
Attovia Therapeutics, Inc. Common Stock (ATTO) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of ATTO with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ATTO analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.